Our Human Products
Sterile Opthalmic Preparations |
||||
| S.N. | Product Name | Label claim | Pack Size | Action & Use |
| STERILE OPHTHALMIC PREPARATIONS | ||||
| 1 | Formulation 1 | Contains | 5gm | Lubricant eye ointment |
| Liquid paraffin IP 42.5% w/w | ||||
| White soft paraffin IP 57.5% w/w | ||||
| Sterile until opened | ||||
| 2 | Formulation 2 | Contains | 5 gm | Corticosteriod & |
| Chloramphenicol BP 1% w/w | 3gm | Antibacterial | ||
| Hydrocortisone Acetate BP 5% w/w | ||||
| 3 | Formulation 3 | Contains | 5 gm | Antibacterial |
| Chloramphenicol BP 1% | (Cojuctivities,keratitis | |||
| Sterile Ointment base q.s. | Corneal Ulcers, | |||
| Trachoma,Blepharitis | ||||
| 4 | Formulation 4 | Hydrocortisone Acetate BP……1%w/w | 5gm | Corticosteriod & |
| Chloramphenicol BP ……………1% w/w | Antibacterial | |||
| 5 | Formulation 5 | Contains | 5 gm | Antibacterial |
| Tetracycline Hydrochloride USP 1% | (Bacterial infection of | |||
| Sterile ointment base q.s. | the cornea,conjunctiva | |||
| or the eye lids. | ||||
| 6 | Formulation 6 | Tetracycline Hydrochloride USP 3% w/w | 15gm | |
| Ointment Base Q.S | ||||
| 7 | Formulation 7 | Each gm Contains | 5gm | Sulphonamide |
| Sulphacetamide Sodium BP 10% | 4 gm | Antimicrobial | ||
| Sterile Ointment base q.s. | (Simple Eye infection | |||
| such as conjunctivitis | ||||
| Stye,Trachoma etc.) | ||||
| 8 | Formulation 8 | Contains | 5 gm | Antimuscarinic |
| Atropine Sulphate USP 1% w/w | ||||
| Ointment Base | ||||
| 9 | Formulation 9 | Each gm Contains | 3 gm | Antibiotic |
| Polymyxin B Sulphate B.P. …5000 I.U. | ||||
| Chloramphenicol I.P……….. 10 mg | ||||
| Sterile Ointment base q.s. | ||||
| 10 | Formulation 10 | Each gm Contains | 5 gms | Antibiotic |
| Polymyxin B Sulphate B.P. 5000 i.u. | 3 gms | Eye Ointment | ||
| Chloramphenicol I.P 10 mg | ||||
| Dexamethasone Sodium | ||||
| Phosphate I.P. 1 mg | ||||
| Sterile Ointment base q,s. | ||||
| 11 | Formulation 11 | Contains | 3 gm | Antiviral treatment |
| Aciclovir BP 3.0 % w/w | 5 gm | of herpex simplex | ||
| Benzalkonium chloride NF 0.01 % w/w | keratisis | |||
| 12 | Formulation 12 | Aciclovir BP 5% w/w | 5gm | |
| Cream Base | ||||
| 13 | Formulation 13 | Aciclovir BP 3% w/w | 3gm | |
| 14 | Formulation 14 | Contains | 3 gm | Antiinfective treatment |
| Ciprofloxacin Hydrochloride IP 0.3 % w/w | 5 gm | of conjunctivitis and | ||
| Eq. To Ciprofloxacin IP 0.3% w/w | corneal ulcers | |||
| Benzalkonium chloride NF 0.01 % w/w | ||||
| 15 | Formulation 15 | Ciprofloxacin Hydrochloride USP | 3 gm | Antiinfective treatment |
| Equirvalent to Ciprofloxacin 0.3%w/v | 5 gm | of conjunctivitis and | ||
| Sterilized q.s | corneal ulcers | |||
| 16 | Formulation 16 | Contains | 3 gm | Antiinfective treatment |
| Gentamicin Sulphate IP 0.3 % w/w | 5 gm | of Superficial infection | ||
| Eq. To Gentamicin 0.3% w/w | ||||
| Benzalkonium chloride NF 0.01 % w/w | ||||
| 17 | Formulation 17 | Contains | 3 gm | Antiinfective treatment |
| Norfloxacin IP 0.3 % w/w | 5 gm | of Superficial infection | ||
| Benzalkonium chloride NF 0.01 % w/w | ||||
| 18 | Formulation 18 | Contains | 3 gm | Antiinfective treatment |
| Ofloxanic USP 0.3 w/w | 5 gm | of Superficial infection | ||
| Benzalkonium chloride NF 0.01 % w/w | ||||
| 19 | Formulation 19 | Each gm Contains | 5 gm | Antiinfective treatment |
| Polymyxin B Sulphate USP 5000 IU | of eye infection due to | |||
| Bacitracin Zinc USP 400 IU | susceptible organisms | |||
| Neomycin Sulphate USP 3400 IU | ||||
| 20 | Formulation 20 | Each gm contains | 5gm | Antiinfective treatment |
| Neomycin Sulphate USP 5mg | of eye infection due to | |||
| Bacitracin Zinc USP 500 units | susceptible organisms | |||
| 21 | Formulation 21 | Each gm Contains | 3 gm | Antibacterial |
| Gatifloxacin 3.0 mg ( 0.3 % w/w ) | 5 gm | |||
| 22 | Formulation 22 | Each gm Contains | 5 gm | Antibacterial |
| Moxifloxacin Hydrochloride mg Eq. To | ||||
| Moxifloxacin 0.5 % w/w | ||||
| 23 | Formulation 23 | Contains | 3 gm | Anti-inflammatory |
| Fluorometholone USP 0.1 % w/w | 5 gm | Antiallergic | ||
| Benzalkonium chloride NF 0.01 % w/w | ||||
| 24 | Formulation 24 | Contains | 3.5 gm | Antiinfective |
| Cyclosporin Ph.Eur 2 mg/gm | ||||
| 25 | Formulation 25 | Gentamicin Sulphate USP 0.3% | 3gm | Antimicrobial |
| 26 | Formulation 26 | Ciprofloxacin 0.3% w/w | 3gm | Antiinfective treatment |
| (as ciprofloxacin Hydrochloride IP) | of conjunctivitis and | |||
| Chlorbutol IP 0.5% w/w | corneal ulcers | |||
| (As preservative) | ||||
| In Sterilized paraffin base | ||||
| 27 | Formulation 27 | Neomycin Sulfate USP | 15gm | |
| equivalent to Neomycin 1.0% w/w | ||||
| Ointment base q.s. | ||||
| 28 | Formulation 28 | Each gram Contains: | 5gm | |
| Heparin Sodium BP 50 IU | ||||
| Benzyl Nicotinate 2.0mg | ||||
| Sorbic acid BP 1.97mg | ||||